4/A//SEC Filing
Kline Kyle 4/A
Accession 0001193125-26-011926
CIK 0001237831other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:40 PM ET
Size
6.0 KB
Accession
0001193125-26-011926
Insider Transaction Report
Form 4/AAmended
Kline Kyle
Senior Vice President, CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
[F1][F2]2025-12-01−4,896→ 104 totalExercise: $63.68Exp: 2032-01-27→ Class A Common Stock (4,896 underlying)
Footnotes (2)
- [F1]On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock.
- [F2]These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Signature
/s/ Kelly G. Huller, Attorney-in-Fact|2026-01-13
Documents
Issuer
GLOBUS MEDICAL INC
CIK 0001237831
Entity typeother
Related Parties
1- filerCIK 0002080625
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:40 PM ET
- Size
- 6.0 KB